Skip to Content
Merck

725692

Poly(ethylene glycol) dimethacrylate

average MN 20,000, cross-linking reagent polymerization reactions, methacrylate, ≤1, 500 ppm MEHQ as inhibitor (may contain)

Synonym(s):

Polyethylene glycol, PEG dimethacrylate

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
C3H5C(O)(OCH2CH2)nOC(O)C3H5
CAS Number:
NACRES:
NA.23
UNSPSC Code:
12162002
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Product Name

Poly(ethylene glycol) dimethacrylate, average Mn 20,000, contains MEHQ as inhibitor

form

powder

mol wt

average Mn 20,000

contains

MEHQ as inhibitor, ≤1,500 ppm MEHQ as inhibitor (may contain)

reaction suitability

reagent type: cross-linking reagent
reaction type: Polymerization Reactions

bp

>200 °C/2 mmHg (lit.)

transition temp

Tm 59-64 °C

Mw/Mn

≤1.1

Ω-end

methacrylate

α-end

methacrylate

polymer architecture

shape: linear
functionality: homobifunctional

storage temp.

−20°C

SMILES string

OCCO.CC(=C)C(O)=O

InChI

1S/C10H14O4/c1-7(2)9(11)13-5-6-14-10(12)8(3)4/h1,3,5-6H2,2,4H3

InChI key

STVZJERGLQHEKB-UHFFFAOYSA-N

Preparation Note

Synthesized with an initial concentration of ≤1,500 ppm MEHQ


Still not finding the right product?


Storage Class

11 - Combustible Solids

wgk

WGK 1



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library


Articles

조직 공학과 약물 전달과 같은 생명 공학의 진보는 다양한 기능성 바이오 소재에 대한 수요 증가를 동반합니다. 연구의 집중 관심 대상이 되어온 바이오 소재의 한 분야는 바로 하이드로겔으로, 화학적으로나 물리적으로 세포의 자연 환경과 유사하게 닮아 있기 때문에 세포를 키우는 토대로 사용될 수 있습니다. 본 기술 문서에서는 일반적으로 면역 반응을 유발하지 못하기 때문에 생물학적 용도로 적합한 PEG(폴리에틸렌 글리콜) 하이드로겔에 대해 상세하게 논의합니다. PEG는 쉽게 이용할 수 있으며, 손쉽게 고분자를 수정하여 세포 배양을 위한 2D 및 3D 뼈대를 포함한 하이드로겔 구성에 광범위하게 사용할 수 있습니다. 또한 분해성 결합을 통해 치료제 출시를 위한 다양한 응용분야에도 도움을 줍니다.

Progress in biotechnology fields such as tissue engineering and drug delivery is accompanied by an increasing demand for diverse functional biomaterials. One class of biomaterials that has been the subject of intense research interest is hydrogels, because they closely mimic the natural environment of cells, both chemically and physically and therefore can be used as support to grow cells. This article specifically discusses poly(ethylene glycol) (PEG) hydrogels, which are good for biological applications because they do not generally elicit an immune response. PEGs offer a readily available, easy to modify polymer for widespread use in hydrogel fabrication, including 2D and 3D scaffold for tissue culture. The degradable linkages also enable a variety of applications for release of therapeutic agents.

Hydrogel-based biomaterials for cell delivery and tissue regeneration applications are discussed.

View All Articles

Alyssa J Reiffel et al.
PloS one, 8(2), e56506-e56506 (2013-02-26)
Autologous techniques for the reconstruction of pediatric microtia often result in suboptimal aesthetic outcomes and morbidity at the costal cartilage donor site. We therefore sought to combine digital photogrammetry with CAD/CAM techniques to develop collagen type I hydrogel scaffolds and
Xuan Mu et al.
Lab on a chip, 13(8), 1612-1618 (2013-03-05)
Engineering functional vascular networks in vitro is critical for tissue engineering and a variety of applications. There is still a general lack of straightforward approaches for recapitulating specific structures and functions of vasculature. This report describes a microfluidic method that
Pelagie M Favi et al.
Materials science & engineering. C, Materials for biological applications, 33(4), 1935-1944 (2013-03-19)
The culture of multipotent mesenchymal stem cells on natural biopolymers holds great promise for treatments of connective tissue disorders such as osteoarthritis. The safety and performance of such therapies relies on the systematic in vitro evaluation of the developed stem